- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Addressing the Physical, Psychological Complexity of IBD Through Coordinated Care
Eva Szigethy, MD, PhD
Explore how the Specialty Medical Home model transforms care for patients with inflammatory bowel disease (IBD) by integrating mental health support and addressing stigma.
The Specialty Medical Home model is reshaping care for people living with inflammatory bowel disease (IBD). IBD, which includes Crohn disease and ulcerative colitis, is a complex, chronic condition that affects millions of people and requires more than just medical management.
In this episode of Managed Care Cast, the conversation focuses on how patients often face not only debilitating gastrointestinal symptoms but also significant psychological challenges, including anxiety, depression, and the stigma that can come with managing an invisible illness.
Developed and implemented at leading centers including the University of Pittsburgh Medical Center (UPMC), the Cleveland Clinic, and Mount Sinai Hospital, this innovative approach is designed to address both the physical and mental health needs of people with IBD through fully integrated, patient-centered, team-based care. The model combines medical treatment with nutritional counseling and behavioral health services to support patients holistically. At its core is the recognition that gut health and mental health are deeply connected and that improving one requires addressing both.
This work is led by the UPMC Center for High-Value Health Care, which received a Patient-Centered Outcomes Research Institute (PCORI) grant to build and study this coordinated care model. Joining us to discuss the impact are 2 of the leaders behind this effort: Eva Szigethy, MD, PhD, a child and adult psychiatrist specializing in gastropsychiatry, who serves as the clinical lead for the IBD Medical Home at UPMC, and Benjamin Cohen, MD, cosection head and clinical director for IBD at Cleveland Clinic, and a coinvestigator in the PCORI-funded study.
Together, they share how this model reduces stigma, promotes patient engagement, and helps individuals better manage the complexity of IBD, especially as treatment options evolve and access to care becomes more fragmented.
Narration was generated using AI.
Listen above or on one of these podcast services:
Targeting the Root of gMG With Inebilizumab: A Q&A With Richard Nowak, MD, MS
June 24th 2025In this interview, Richard J. Nowak, MD, MS, principal investigator of the MINT trial of inebilizumab for generalized myasthenia gravis (gMG), discusses the trial’s key findings, including significant improvements in patient- and physician-assessed outcomes, as well as longer-term implications and future areas of investigation.
Read More
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
Accessibility Important After FDA Approves Lenacapavir for PrEP: Q&A With Colleen Kelley, MD, MPH
June 20th 2025The approval of lenacapavir, a form of pre-exposure prophylaxis (PrEP), marks significant progress in preventing HIV, making it vital for the treatment to be available and accessible to those most vulnerable, explains Colleen Kelley, MD, MPH, Rollins School of Public Health at Emory University.
Read More
AMGA Releases Population Health Framework to Improve ASCVD Secondary Prevention
June 18th 2025Proven interventions to improve care, address disparities, and support lipid management are woven throughout AMGA Foundation's new framework to guide population health–based secondary prevention strategies for atherosclerotic cardiovascular disease (ASCVD).
Read More
